— Know what they know.
Not Investment Advice

603882.SS SHH

Guangzhou Kingmed Diagnostics Group Co., Ltd.
1W: +0.0% 1M: +6.1% 3M: +24.1% YTD: -9.5% 1Y: -3.8% 3Y: -58.6% 5Y: -77.8%
¥29.06 ($4.33)
+0.81 (+2.87%)
 
SHH · Healthcare · Medical - Diagnostics & Research · Tech Score Strong Buy · Power 68 · ¥13.5B mcap · 298M float · 2.94% daily turnover

Cash Flow Trends

Operating Cash Flow
$906M -26.4% ▼
5Y CAGR: +6.5%
Capital Expenditures
$446M +37.5% ▲
5Y CAGR: +10.2%
Free Cash Flow
$460M -10.9% ▼
5Y CAGR: +3.5%
Dividends Paid
$420M +50.0% ▲
Buybacks
$210M -133.3% ▼
Net Change in Cash
-$27M +94.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$1.6B$2.4B$2.8B$637M-$415M
Depreciation & Amort.$281M$426M$528M$679M$554M
Stock-Based Comp.$46M$133M$102M$0$0
Change in Working Capital-$539M-$1.1B-$1.9B-$228M-$100M
Other Non-Cash Items$153M$224M$394M$144M$867M
Operating Cash Flow$1.5B$2.1B$1.9B$1.2B$906M
— Investing Activities —
Capital Expenditures-$551M-$952M-$841M-$715M-$446M
Acquisitions (Net)$11M$83M-$22M$211M$0
Investment Purchases-$77M-$134M-$18M-$151M-$26M
Investment Sales$3M$3M$12M$482K$2M
Other Investing-$20M-$9M$20M$19M$15M
Investing Cash Flow-$634M-$1.0B-$848M-$635M-$456M
— Financing Activities —
Net Debt Issuance-$153M-$82M-$99M$2M$270M
Stock Repurchased$0$0$0-$90M-$210M
Dividends Paid-$62M-$152M-$596M-$839M-$420M
Other Financing$30M$202M-$160M-$225M-$129M
Financing Cash Flow-$214M-$53M-$869M-$1.1B-$489M
Net Change in Cash$671M$1.0B$270M-$458M-$27M
Cash End of Period$1.6B$2.6B$2.9B$2.4B$2.4B
Free Cash Flow$972M$1.1B$1.1B$516M$460M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms